Coronary heart disease (CHD), also known as coronary artery disease, is one of the most common types of heart disease. In 2019 alone, 3,740 people died of the disease in Hong Kong. CHD may be categorized as either chronic or acute, and acute CHD has a mortality rate of up to 30%. CHD patients who fail to receive vascular treatment (such as thrombolytic therapy, angioplasty, or coronary artery bypass graft (CABG)) within the first four hours of symptom onset are at greater risk of developing complications.
What is Angioplasty?
CHD occurs when plaques build up in the arteries (major vessels that supply blood to the heart), which leads to a narrowing or blockage of the arteries and insufficient blood supply to the heart. When this happens, patients may experience angina pectoris (chest pain), myocardial infarction (heart attack), and in severe cases, myocardial necrosis (cell death of cardiomyocytes) or even death.
Patients with an artery that is 70% narrowed or blocked, or those admitted to the hospital for acute CHD may require angioplasty. Today, angioplasty is performed through a minimally invasive approach, which offers advantages such as less surgical trauma and a high success rate. Both angioplasty and coronary artery bypass graft are effective in restoring blood flow to the heart.